Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers

Clinical trial NCT00750282 · COMPLETED

Trial details

NCT number: NCT00750282
Sponsor: Lantheus Biosciences Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Amyloid Beta-Protein

Start date: 2008-08-01
Primary completion: 2010-11-01
Enrollment: 422

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.